Zeel®

Written by

Urenus

in

Compositions:

Tablets: 1 tablet containing: Cartilago suis D4 0.3 mg, Funiculus umbilicalis suis D4 0.3 mg, Embryo totalis suis D4 0.3 mg, Placenta totalis suis D4 0.3 mg, Rhus toxicodendron D2 0.54 mg, Arnica montana D1 0.6 mg, Solanum dulcamara D2 0.15 mg, Symphytum officinale D8 0.15 mg, Sanguinaria canadensis D3 0.45 mg, Sulfur D6 0.54 mg, Nadidum D6 0.03 mg, Coenzyme A D6 0.03 mg, Natrium diethyloxalaceticum D6 0.03 mg, Acidum DL-alpha liponicum D6 0.03 mg, Acidum silicicum D6 3 mg.

Injection solution: 1 ampoule of 2.0 ml (≈ 2.0 g) contains: Cartilago suis D6 2 mg, Funiculus umbilicalis suis D6 2 mg, Embryo totalis suis D6 2 mg, Placenta totalis suis D6 2 mg, Solanum dulcamara D3 10 mg, Symphytum officinale D6 10 mg, Nadidum D8 2 mg, Coenzyme A D8 2 mg, Sanguinaria canadensis D4 3 mg, Natrium diethyloxalaceticum D8 2 mg, Acidum DL-alpha liponicum D8 2 mg, Rhus toxicodendron D2 10 mg, Arnica montana D4 200 mg, Sulfur D6 3.6 mg.

Ointment: 100 g containing: Cartilago suis D2, Funiculus umbilicalis suis D2, Embryo suis D2, Placenta suis D2 0.001 g each; Rhus toxicodendron D2 0.270 g; Arnica montana D2 0.3 g; Solanum dulcamara D2 0.075 g; Symphytum officinale D8 0.75 g; Sanguinaria canadensis D2 0.225 g; Sulfur D6 0.27 g; Nadidum D6, Coenzyme A D6, Acidum DL-alpha liponicum D6, Natrium diethyloxalaceticum D6 0.01 g each; Acidum silicicum D6 1.0 g.

Ointment base: Hydrophilic ointment (DAB 10) containing: emulsifying cetostearyl alcohol (type A), ethanol, purified water, liquid paraffin, white soft paraffin, preserved with 12.8 vol.-% alcohol.


Indications:

Arthrosis/osteoarthritis, in particular knee arthrosis, polyarthrosis, spondylarthrosis, rotator cuff syndrome. Rheumatic joint diseases.


Contraindications:

Known allergy (hypersensitivity) to one or more of the ingredients. Do not use during pregnancy and lactation.


Side effects:

Tablets, injection solution: Allergic (hypersensitivity) skin reactions may occur in very rare cases (i.e. affects less than 1 in 10,000 users).


Interactions with other medication:

None known.


Dosage:

Tablets – Standard dosage: Adults (and children 12 yrs. and older): 1 tablet to be dissolved in the mouth 3x daily. Acute or initial dosage: 1 tablet every ½ to 1 hr., up to 12x daily, then continue with standard dosage.

Injection solution – Standard dosage: Adults and children 12 yrs. and older: 1 ampoule 1 to 3x weekly. May be administered by s.c., i.d., i.m., i.a. or i.v. route. Acute or initial dosage: 1 ampoule daily, then continue with standard dosage.

Ointment – Standard dosage: Adults (and children 12 yrs. and older): Apply 2 to 4x daily. For external use only. Apply a thin layer over the affected area.


Package sizes:

  • Tablets: Packs containing 50 and 250 tablets. (9757)
  • Injection solution: Packs containing 10 and 100 ampoules of 2.0 ml each. (8705)
  • Ointment: Tubes containing 50 and 100 g of ointment. (9588)


Clinical notes:

Zeel may protect against aspects of cartilage damage. The chondrocyte, which is the “control center” of the cartilage, regulates the oscillatory cycle of tissue destruction and regeneration, influenced by IL-6, IL-1, and TNF-α. These cytokines affect matrix metalloproteinases and synthesis of other substances. The regenerative cycle is supported by transforming growth factor-β and plant-based ingredients in Zeel.

Zeel’s ingredients such as sulfur and cartilage-based tissue materials (e.g., Cartilago suis and Funiculus umbilicalis suis) may support connective tissue regeneration and modulate inflammation.

References

  1. Clarke JH. A Dictionary of Practical Materia Medica. Vol 1–3. 3rd ed. Bradford, England: Health Science Press; 1977.
  2. Hering C. The Guiding Symptoms of Our Materia Medica. Vol 1–10. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
  3. Murphy R. Homeopathic Medical Repertory: A Modern Alphabetical Repertory. 1st ed. Pagaso Springs, CO: Hahnemann Academy of North America; 1993.
  4. Schroyens F. Synthesis: Repertorium Homeopathicum Syntheticum. 9th ed. London, England: Homeopathic Book Publishers; 2004.
  5. Allen TF. The Encyclopedia of Pure Materia Medica: A Record of the Positive Effects of Drugs Upon the Healthy Human Organism. Vol 1–12. 1st ed. Ridgewood, NJ: Gregg Press Inc; 1964.
  6. Allen TF. Handbook of Materia Medica and Homeopathic Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1889.
  7. Boericke W. Pocket Manual of Homoeopathic Materia Medica With Repertory, Comprising the Characteristic and Guiding Symptoms of All Remedies. 9th ed. Santa Rosa, CA: Boericke & Tafel; 1927.
  8. Burt WH. Physiological Materia Medica. 5th ed. Chicago, IL: Gross & Delbridge; 1896.
  9. Gibson DM. Studies of Homeopathic Remedies. 1st ed. Beaconsfield, England: Beaconsfield Publishers Ltd; 1987.
  10. Hoyne TS. Clinical Therapeutics. Vol 1–2. New Delhi, India: Jain Publishers Ltd; 1979.
  11. Hughes R, Dake JP. A Cyclopaedia of Drug Pathogenesis. Vol 1–4. 1st ed. New Delhi, India: World Homoeopathic Links; 1891.
  12. Kent JT. Lectures on Homeopathic Materia Medica. 4th ed. London, England, New York, NY, Philadelphia, PA: Boericke & Tafel; 1946.
  13. Kulkarni S. Gynaecologic and Obstetric Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1994.
  14. Lilienthal S. Homeopathic Therapeutics. 5th ed. Calcutta, India: Sett Dey & Co; 1925.
  15. Morrison R. Desktop Companion to Physical Pathology. 1st ed. Albany, CA: Hahnemann Clinic Publishing; 1998.
  16. Allen HC. Keynotes and Characteristics With Comparisons of Some of the Leading Remedies of the Materia Medica. 1st ed. Wellingborough, England: Thorsons Publishers Ltd; 1987.
  17. Allen HC. The Therapeutics of Intermittent Fever. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1884.
  18. Blackwood AL. A Manual of Materia Medica, Therapeutics and Pharmacology (With Clinical Index). 2nd ed. New Delhi, India: World Homoeopathic Links; 1922.
  19. Choudhuri NM. A Study on Materia Medica and Repertory. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1988.
  20. Cleveland CL. Salient Materia Medica and Therapeutics. 1st ed. New Delhi, India: Jain Publishers Ltd; 1888.
  21. Degroote F. Physical Examination and Observations in Homoeopathy. 1st ed. Gent, Belgium: Homoeoden Bookservice; 1992.
  22. Dewey WA. Practical Homeopathic Therapeutics. 3rd ed. Philadelphia, PA: Boericke & Tafel; 1934.
  23. Douglass MF. Pearls of Homeopathy. 1st ed. New Delhi, India: Jain Publishers Ltd; 1903.
  24. Farrington EA. The Clinical Materia Medica Being a Course of Lectures Delivered at the Hahnemann Medical College, of Philadelphia. 2nd ed. Philadelphia, PA: Hahnemann Publishing House; 1900.
  25. Farrington EA. Lesser Writings With Therapeutic Hints. 1st ed. Calcutta, India: Salzer & Co; 1935.
  26. Mohanty N. Text-Book of Homoeopathic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1997.
  27. Royal G. Textbook of Homoeopathic Materia Medica. 1st ed. Calcutta, India: Roy Publishing House; 1920.
  28. Murphy R. The Homeopathic Remedy Guide: 1200 Homeopathic and Herbal Remedies. 1st ed. Blacksburg, VA: HANA Press; 2000.
  29. Vermeulen F. Concordant Materia Medica. 2nd ed. Haarlem, the Netherlands: Merlijn Publishers; 1997.
  30. Phatak SR. Materia Medica of Homeopathic Medicines. 1st ed. London, England: Foulke-Vaughan Publishers; 1988.
  31. Dunham C. Lectures on Materia Medica. 3rd ed. London, England, New York, NY, Philadelphia, PA: Boericke & Tafel; 1934.
  32. Vermeulen F. Synoptic Materia Medica. Vol 1. 6th ed. Haarlem, the Netherlands: Merlijn Publishers; 2000.
  33. Hahnemann S. Materia Medica Pura. Vol 1–2. 1st ed. London, England: Homeopathic Book Publishers; 1800.
  34. Hahnemann S. The Chronic Diseases, Their Peculiar Nature and Their Homoeopathic Cure. Tafel LH, trans-ed. Vol 1–2. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1981.
  35. Wheeler CE. An Introduction to the Principles and Practice of Homoeopathy. 3rd ed. Saffron Walden, England: CW Daniel Co Ltd; 1948.
  36. Hughes R. Manual of Homoeopathic Pharmacodynamics. 5th ed. London, England: Leath & Ross; 1886.
  37. Boer CRM. A Synoptic Key of the Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1931.
  38. Buck H. The Outlines of Materia Medica and a Clinical Dictionary. 1st ed. New Delhi, India: Jain Publishers Ltd; 1865.
  39. Burt WH. Characteristic Materia Medica. 1st ed. New Delhi, India: Jain Publishers Ltd; 1978.
  40. Farrington EA. Comparative Materia Medica. 3rd ed. New Delhi, India: Jain Publishers Ltd; 1983.
  41. Farrington EA. Clinical Materia Medica Being a Course of Lectures Delivered at the Hahnemann Medical College, of Philadelphia. 2nd ed. Philadelphia, PA: Hahnemann Publishing House; 1900.
  42. Lippe A. Keynotes and Red Line Symptoms of Materia Medica. New Delhi, India: Jain Publishers Ltd; 1998.
  43. Allen MF. Special Symptomatology of the New Remedies. New Delhi, India: Jain Publishers Ltd.
  44. Allen TF. A Primer of Materia Medica for Practitioners of Homoeopathy. 1st ed. Philadelphia, PA: Boericke & Tafel; 1892.
  45. Reinhart E. Suis-Orgnpräparate in der Homotoxikologie. 1st ed. Baden-Baden, Germany: Aurelia Verlag; 1994.
  46. Reckeweg H-H. Homoeopathia Antihomotoxica–Symptomen- und Modalitätenverzeichnis mit Arzneimittellehre. Vol 1–2. 6th ed. Baden-Baden, Germany: Aurelia Verlag; 1999.
  47. Schmidt F, Baumgärtel A. Antihomotoxische Medizin–Band II: Homöopathische Antihomotoxica. Vol 2. 1st ed. Baden-Baden, Germany: Aurelia Verlag; 1996.
  48. Gupta RL. Director of Diseases and Cures in Homoeopathy: 1500 Authoritative References With Causes & Symptoms. Vol 1–2. 1st ed. New Delhi, India: Jain Publishers Ltd; 1989.
  49. Rastogi DP. Homoeopathic Gems. 2nd ed. New Delhi, India: Jain Publishers Ltd; 1993.
  50. Vermeulen F. Synoptic Materia Medica Illustrated–Similarities and Parallels Between Substance and Remedy. 2nd ed. Haarlem, the Netherlands: Merlijn Publishers; 2002.
  51. Plotnik M, Siman R. Biomodulation of osteoarthritis. J Biomed Ther. 2008;2:47–4.